Skip to main content

Together we are beating cancer

Donate now

For Researchers | Analysis

Read analysis articles in our For Researchers section
Showing 12 out of 61 results
Academic publishing

The open access movement was bold and promising, but ultimately disappointing. Now is the time to stop and call for a new way to make publishing work… The open access movement was bold and promising, but ultimately disappointing. Now is the time to stop and call for a new way to make publishing work…

by Cancer Research UK | Analysis | 1 April 2026

1 April 2026

This entry is part 2 of 2 in the series Minding the gap
Big data

We are awash with data – but how do cancer researchers make the most of it at the scale and pace needed whilst also keeping the trust of patients? We are awash with data – but how do cancer researchers make the most of it at the scale and pace needed whilst also keeping the trust of patients?

by Cancer Research UK | Analysis | 24 February 2026

24 February 2026

This entry is part 2 of 2 in the series Data science
Careers

Good leadership is vital for successful science – so how, exactly, do you get good at it? Ally Walters talks us through it... Good leadership is vital for successful science – so how, exactly, do you get good at it? Ally Walters talks us through it...

by Cancer Research UK | Analysis | 11 February 2026

11 February 2026

This entry is part 8 of 8 in the series Research Careers
Minding the gap

Tim Bodicoat ponders the thawing of the biotech winter and asks if the market can ever tell you if it’s the right time to launch a start-up… Tim Bodicoat ponders the thawing of the biotech winter and asks if the market can ever tell you if it’s the right time to launch a start-up…

by Tim Bodicoat | Analysis | 3 February 2026

3 February 2026

This entry is part 1 of 2 in the series Minding the gap
Up and running - how to speed up clinical trials

The UK is ideally suited for early phase oncology trials, so is it possible to speed up set-up time? Sharan Sandhu tells us how we could... The UK is ideally suited for early phase oncology trials, so is it possible to speed up set-up time? Sharan Sandhu tells us how we could...

by Phil Prime | Analysis | 15 December 2025

15 December 2025

Data science column

LLMs are impressive yet they also pose a threat to science. The first column in our new series on data science gets into the dichotomy... LLMs are impressive yet they also pose a threat to science. The first column in our new series on data science gets into the dichotomy...

by Cancer Research UK | Analysis | 11 November 2025

11 November 2025

This entry is part 1 of 2 in the series Data science
Careers

Clinical academics hold a vital place in the cancer research landscape; so why is it proving so hard to retain them, and what can we do about it? Clinical academics hold a vital place in the cancer research landscape; so why is it proving so hard to retain them, and what can we do about it?

by Cancer Research UK | Analysis | 14 October 2025

14 October 2025

This entry is part 7 of 8 in the series Research Careers
ageing

The transition from normal to pre-cancerous tissue remains underexplored. Ageing research, by contrast, has long studied normal tissue decline... The transition from normal to pre-cancerous tissue remains underexplored. Ageing research, by contrast, has long studied normal tissue decline...

by Cancer Research UK | Analysis | 27 August 2025

27 August 2025

This entry is part 16 of 16 in the series Research Integrity